Six individuals diagnosed with Sotos syndrome and carrying pathogenic NSD1 mutations (Table 1) were initially tested to confirm the robustness and specificity of the previously identified disease-specific signature [17]. This evidence concerns the gene NSD1 and Sotos syndrome.